Table of Content

Table of Contents

Global Cell-based Flu Vaccine Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Cell-based Flu Vaccine Market by Value
2.2.1 Global Cell-based Flu Vaccine Revenue by Type
2.2.2 Global Cell-based Flu Vaccine Market by Value (%)
2.3 Global Cell-based Flu Vaccine Market by Production
2.3.1 Global Cell-based Flu Vaccine Production by Type
2.3.2 Global Cell-based Flu Vaccine Market by Production (%)

3. The Major Driver of Cell-based Flu Vaccine Industry
3.1 Historical & Forecast Global Cell-based Flu Vaccine Demand
3.2 Largest Application for Cell-based Flu Vaccine (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Cell-based Flu Vaccine Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Cell-based Flu Vaccine Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Cell-based Flu Vaccine Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Cell-based Flu Vaccine Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Cell-based Flu Vaccine Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Cell-based Flu Vaccine Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Cell-based Flu Vaccine Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Cell-based Flu Vaccine Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Cell-based Flu Vaccine Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Cell-based Flu Vaccine Average Price Trend
12.1 Market Price for Each Type of Cell-based Flu Vaccine in US (2018-2022)
12.2 Market Price for Each Type of Cell-based Flu Vaccine in Europe (2018-2022)
12.3 Market Price for Each Type of Cell-based Flu Vaccine in China (2018-2022)
12.4 Market Price for Each Type of Cell-based Flu Vaccine in Japan (2018-2022)
12.5 Market Price for Each Type of Cell-based Flu Vaccine in India (2018-2022)
12.6 Market Price for Each Type of Cell-based Flu Vaccine in Korea (2018-2022)
12.7 Market Price for Each Type of Cell-based Flu Vaccine in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Cell-based Flu Vaccine Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Cell-based Flu Vaccine

14. Cell-based Flu Vaccine Competitive Landscape
14.1 GlaxoSmithKline
14.1.1 GlaxoSmithKline Company Profiles
14.1.2 GlaxoSmithKline Product Introduction
14.1.3 GlaxoSmithKline Cell-based Flu Vaccine Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Sanofi
14.2.1 Sanofi Company Profiles
14.2.2 Sanofi Product Introduction
14.2.3 Sanofi Cell-based Flu Vaccine Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Pfizer
14.3.1 Pfizer Company Profiles
14.3.2 Pfizer Product Introduction
14.3.3 Pfizer Cell-based Flu Vaccine Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 MedImmune, LLC
14.4.1 MedImmune, LLC Company Profiles
14.4.2 MedImmune, LLC Product Introduction
14.4.3 MedImmune, LLC Cell-based Flu Vaccine Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Intravacc
14.5.1 Intravacc Company Profiles
14.5.2 Intravacc Product Introduction
14.5.3 Intravacc Cell-based Flu Vaccine Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 CSL Limited
14.6.1 CSL Limited Company Profiles
14.6.2 CSL Limited Product Introduction
14.6.3 CSL Limited Cell-based Flu Vaccine Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 E. Merck KG
14.7.1 E. Merck KG Company Profiles
14.7.2 E. Merck KG Product Introduction
14.7.3 E. Merck KG Cell-based Flu Vaccine Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Novartis
14.8.1 Novartis Company Profiles
14.8.2 Novartis Product Introduction
14.8.3 Novartis Cell-based Flu Vaccine Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Danaher Corporation
14.9.1 Danaher Corporation Company Profiles
14.9.2 Danaher Corporation Product Introduction
14.9.3 Danaher Corporation Cell-based Flu Vaccine Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 SINOVAC
14.10.1 SINOVAC Company Profiles
14.10.2 SINOVAC Product Introduction
14.10.3 SINOVAC Cell-based Flu Vaccine Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Cell-based Flu Vaccine Industry (Volume)
Figure 2. Cell-based Flu Vaccine Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Cell-based Flu Vaccine Revenue in 2022
Figure 5. US Cell-based Flu Vaccine Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Cell-based Flu Vaccine Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Cell-based Flu Vaccine Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Cell-based Flu Vaccine Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Cell-based Flu Vaccine Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Cell-based Flu Vaccine Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Cell-based Flu Vaccine Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Cell-based Flu Vaccine Revenue, by Type (Million USD) (2018-2028)
Table 4. Cell-based Flu Vaccine Production, by Type (K Unit) (2018-2028)
Table 5. Cell-based Flu Vaccine Demand (K Unit) by Application (2018-2028)
Table 6. Cell-based Flu Vaccine Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Cell-based Flu Vaccine Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Cell-based Flu Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Cell-based Flu Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Cell-based Flu Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Cell-based Flu Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Cell-based Flu Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Cell-based Flu Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Cell-based Flu Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Cell-based Flu Vaccine in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Cell-based Flu Vaccine in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Cell-based Flu Vaccine in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Cell-based Flu Vaccine in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Cell-based Flu Vaccine in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Cell-based Flu Vaccine in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Cell-based Flu Vaccine in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. GlaxoSmithKline Profiles
Table 61. GlaxoSmithKline Cell-based Flu Vaccine Product Introduction
Table 62. GlaxoSmithKline Cell-based Flu Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. GlaxoSmithKline Strategic initiatives
Table 64. Sanofi Profiles
Table 65. Sanofi Cell-based Flu Vaccine Product Introduction
Table 66. Sanofi Cell-based Flu Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Sanofi Strategic initiatives
Table 68. Pfizer Profiles
Table 69. Pfizer Cell-based Flu Vaccine Product Introduction
Table 70. Pfizer Cell-based Flu Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Pfizer Strategic initiatives
Table 72. MedImmune, LLC Profiles
Table 73. MedImmune, LLC Cell-based Flu Vaccine Product Introduction
Table 74. MedImmune, LLC Cell-based Flu Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. MedImmune, LLC Strategic initiatives
Table 76. Intravacc Profiles
Table 77. Intravacc Cell-based Flu Vaccine Product Introduction
Table 78. Intravacc Cell-based Flu Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Intravacc Strategic initiatives
Table 80. CSL Limited Profiles
Table 81. CSL Limited Cell-based Flu Vaccine Product Introduction
Table 82. CSL Limited Cell-based Flu Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. CSL Limited Strategic initiatives
Table 84. E. Merck KG Profiles
Table 85. E. Merck KG Cell-based Flu Vaccine Product Introduction
Table 86. E. Merck KG Cell-based Flu Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. E. Merck KG Strategic initiatives
Table 88. Novartis Profiles
Table 89. Novartis Cell-based Flu Vaccine Product Introduction
Table 90. Novartis Cell-based Flu Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Novartis Strategic initiatives
Table 92. Danaher Corporation Profiles
Table 93. Danaher Corporation Cell-based Flu Vaccine Product Introduction
Table 94. Danaher Corporation Cell-based Flu Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Danaher Corporation Strategic initiatives
Table 97. SINOVAC Profiles
Table 98. SINOVAC Cell-based Flu Vaccine Product Introduction
Table 99. SINOVAC Cell-based Flu Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. SINOVAC Strategic initiatives